MaxLinear
MXL
$105.93
+14.99%
MaxLinear, Inc. is a fabless semiconductor company that designs radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and data center, metro, and long-haul fiber networks, with its RF receiver products and systems-on-chips enabling the distribution and display of broadband video and data across a wide range of electronic devices. The company occupies a specialized niche in the analog/mixed-signal semiconductor space, competing against larger diversified chipmakers while positioning itself as a critical enabler of broadband infrastructure and, increasingly, AI data-center connectivity. The current investor narrative has shifted dramatically toward the AI infrastructure build-out, with the company's infrastructure segment surging and headlines such as "Is MaxLinear the Next AI Stock to 10X?" capturing the market's imagination after a blowout Q1 earnings report that sent shares rocketing. This AI-driven re-rating has transformed MXL from a struggling broadband supplier into a high-beta momentum story, though the company remains unprofitable on a GAAP basis and the debate now centers on whether the AI infrastructure growth is durable enough to justify the extraordinary share-price appreciation.…
MXL
MaxLinear
$105.93
Related headlines
Investment Opinion: Should I buy MXL Today?
The synthesized recommendation is Hold, with a neutral bias. While the analyst consensus is 'buy' (mean 1.82) and the average target of $94.55 implies minimal upside, the company's persistent losses and extreme valuation metrics warrant caution. The core thesis is that MaxLinear's AI infrastructure growth is real but already priced in, and the risk/reward is balanced at current levels.
Supporting evidence includes the 43% YoY revenue growth in Q1 2026, gross margin expansion to 57.5%, and a low debt-to-equity of 0.348. However, the net margin of -29.2% and negative free cash flow of -$10.26 million highlight ongoing profitability challenges. The forward PE of 35.91x is below the historical positive PE range of 20-73x, but the EV/Sales of 13.75x is elevated. Analyst targets range widely from $40 to $125, reflecting high uncertainty. The stock's beta of 3.945 and max drawdown of -55.28% underscore the high risk.
The biggest risks that could invalidate the thesis include a slowdown in AI infrastructure spending, continued cash burn leading to dilution, and competitive pressures. The rating would upgrade to Buy if the company demonstrates sustained positive free cash flow and revenue growth accelerates above 50% YoY. It would downgrade to Sell if revenue growth decelerates below 20% or if gross margins fall below 55%. Relative to its history, the stock is fairly valued on a forward PE basis but overvalued on EV/Sales and price-to-free-cash-flow, suggesting limited margin of safety.
Sign up to view all
MXL 12-Month Price Forecast
MaxLinear presents a high-risk, high-reward opportunity with a neutral stance due to balanced risk/reward. The AI infrastructure growth is compelling, but the stock's valuation and unprofitability leave little margin for error. The analyst consensus is bullish, but the average target suggests the stock is fully valued. The extreme beta and recent drawdown highlight the potential for sharp declines. An upgrade to bullish would require sustained positive free cash flow and revenue growth above 50%, while a downgrade to bearish would be triggered by decelerating growth or margin compression.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MaxLinear's 12-month outlook, with a consensus price target around $94.55 and implied upside of -10.8% versus the current price.
Average Target
$94.55
0 analysts
Implied Upside
-10.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$40 - $125
Analyst target range
MaxLinear is covered by 11 analysts with a consensus recommendation of "buy" (recommendation mean of 1.818 on a scale where 1 is Strong Buy and 5 is Strong Sell), and the average price target of $94.55 implies just +0.75% upside from the current price of $93.84 — essentially the stock is trading at fair value relative to consensus. The Buy/Hold/Sell distribution is not fully specified, but the recommendation mean of 1.82 and the recent institutional ratings pattern — Stifel reiterating Buy, Loop Capital upgrading from Hold to Buy, Needham upgrading from Hold to Buy, and Benchmark maintaining Buy — indicate a decidedly bullish tilt with a clear upgrade cycle underway. The consensus leans bullish, but the minimal implied upside suggests the market has already caught up to analyst expectations, and the stock's 487.97% 1-year gain means analysts have been playing catch-up with the price rather than leading it.
The target range is extraordinarily wide, from a low of $40.00 to a high of $125.00 — a 3.1x spread that signals very high uncertainty and low conviction about the company's future earnings power. The high target of $125.00 (roughly 33% above current levels) assumes successful execution on the AI infrastructure opportunity, continued revenue acceleration, and eventual margin expansion toward semiconductor norms, while the low target of $40.00 (roughly 57% below current levels) prices in a scenario where AI demand disappoints, competition intensifies, or the company fails to convert revenue growth into profitability. The estimated EPS range of $2.97 to $3.77 and revenue range of $1.10 billion to $1.32 billion for the forward period further illustrate the dispersion in expectations. The recent upgrade activity (two Hold-to-Buy upgrades in April 2026) is a positive signal, but the wide target spread and the fact that the average target sits almost exactly at the current price suggest that the easy money has been made and future returns will depend on whether the company can deliver on the optimistic end of its guidance.
Bulls vs Bears: MXL Investment Factors
The bull case rests on explosive AI-driven revenue growth (43% YoY) and a consensus buy rating, but the bear case highlights persistent GAAP losses (-$45.14 million in Q1 2026) and extreme valuation multiples (EV/Sales of 13.75x). The most critical tension is whether the AI infrastructure growth is durable enough to justify the forward PE of 35.91x and drive the company to sustained profitability. Currently, the bear evidence appears stronger due to negative cash flow and the stock's 55.28% max drawdown, which underscores the risk of momentum reversal. However, the upgrade cycle and 136% segment growth provide a powerful counter-narrative that could quickly shift sentiment if upcoming earnings confirm the trend.
Bullish
- Explosive AI infrastructure revenue growth: Q1 2026 revenue of $137.19 million grew 43% year-over-year, driven by the Infrastructure segment which surged 136% according to news reports. This segment is now the largest at $62.81 million, representing 45.8% of total revenue, and is directly tied to the AI data-center build-out.
- Analyst consensus buy with upgrade cycle: 11 analysts rate MXL a 'buy' with a recommendation mean of 1.82 (1=Strong Buy). Recent upgrades from Stifel, Loop Capital, and Needham signal improving sentiment, and the average target of $94.55 is essentially at the current price, suggesting analysts see fair value but not overvaluation.
- Gross margin expansion and stable profitability: Gross margin improved from 55.50% in Q1 2025 to 57.50% in Q1 2026, demonstrating pricing power and operational efficiency. This 200 basis point expansion occurred despite revenue growing 43%, indicating scalable unit economics.
- Low debt and manageable balance sheet: Debt-to-equity is only 0.348 and the current ratio is 1.34, providing financial flexibility. With $89.93 million in cash, the company can fund R&D investments ($53.16 million in Q1 2026) without immediate liquidity concerns.
Bearish
- Persistent GAAP losses and negative cash flow: Q1 2026 net income was -$45.14 million (net margin -32.9%) and free cash flow turned negative at -$10.26 million. The company remains unprofitable on a GAAP basis, with operating margin at -12.2%, and relies on cash reserves to fund operations.
- Extreme volatility and high beta: Beta is 3.945, meaning MXL is nearly 4x more volatile than the market. The stock experienced a max drawdown of -55.28% from June to August 2026, and the 52-week range of $12.77 to $128.30 represents a 10x spread, highlighting extreme risk.
- Valuation leaves no room for error: EV/Sales is 13.75x and price-to-free-cash-flow is 76.93x, both elevated for a company with negative EBITDA. The forward PE of 35.91x prices in flawless execution, and any disappointment could trigger a sharp re-rating.
- Wide analyst target dispersion signals uncertainty: Analyst targets range from $40 to $125, a 3.1x spread, indicating low conviction. The average target of $94.55 offers only 0.75% upside, suggesting the stock is fully valued relative to consensus.
MXL Technical Analysis
MaxLinear is in the midst of a violent, parabolic uptrend that has produced a 1-year price change of +487.97% and a year-to-date gain of +406.97%, utterly dwarfing the S&P 500's +17.22% and +13.11% over the same periods. At a current price of $93.84, the stock sits at roughly 70.4% of its 52-week range (52-week low of $12.77, 52-week high of $128.30), meaning it has surrendered meaningful ground from its peak despite the massive annual gain. This positioning is characteristic of a high-momentum name that has already priced in enormous optimism but is now digesting a sharp correction from its highs, leaving it vulnerable to further mean-reversion while still carrying substantial trend strength. The 52-week range itself is extraordinary — a low of $12.77 to a high of $128.30 represents a more than 10x spread, underscoring the extreme volatility embedded in this name.
Recent momentum is sharply bifurcated: the 1-month change of +48.95% shows a powerful re-acceleration, yet the 3-month change of -2.86% reveals that the stock is essentially flat-to-down over the quarter, having peaked near $128.30 in late June before a brutal drawdown to the $57-$59 area in late July and early August. The 1-month surge of nearly 49% against a 3-month decline of 2.86% signals a classic V-shaped recovery attempt following a severe correction, with the stock rebounding from the $57.59 close on September 1 to $93.84 by September 25 — a gain of roughly 63% in under a month. This divergence between the explosive short-term rebound and the negative intermediate trend suggests the stock is in a high-volatility recovery phase where dip-buyers have regained control, but the failure to reclaim the June highs leaves the longer-term uptrend unconfirmed. The relative strength versus SPY is telling: +48.26% over 1 month and +470.75% over 1 year, but -8.67% over 3 months, confirming that MXL's outperformance is concentrated in sharp bursts rather than steady trend.
Key technical levels are well-defined by the 52-week range: support rests at the 52-week low of $12.77, though the more relevant near-term support zone is the $57-$59 area that held during the July/August selloff, while resistance sits at the 52-week high of $128.30. A breakout above $128.30 would signal a resumption of the primary uptrend and likely trigger momentum-chasing inflows, whereas a breakdown below the $57 support would confirm a lower-high/lower-low structure and potentially open the door to a retest of the $40s. The stock's beta of 3.945 is extraordinarily high — nearly 4x the volatility of the broader market — meaning a 1% move in SPY theoretically corresponds to a ~3.95% move in MXL, which has profound implications for position sizing and risk management; a max drawdown of -55.28% over the period confirms that this name can lose more than half its value in a correction, as it did from June to August.
Beta
3.94
3.94x market volatility
Max Drawdown
-55.3%
Largest decline past year
52-Week Range
$13-$128
Price range past year
Annual Return
+553.9%
Cumulative gain past year
| Period | MXL Return | S&P 500 |
|---|---|---|
| 1m | +76.3% | +0.6% |
| 3m | +13.8% | +3.3% |
| 6m | +489.2% | +17.4% |
| 1y | +553.9% | +15.0% |
| ytd | +472.3% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MXL Fundamental Analysis
MaxLinear's revenue trajectory has inflected sharply upward, with Q1 2026 (quarter ended 2026-03-31) revenue of $137.19 million representing 43% year-over-year growth versus the $95.93 million reported in Q1 2025. The multi-quarter trend shows consistent sequential improvement: revenue climbed from $108.81 million in Q2 2025 to $126.46 million in Q3 2025 to $136.44 million in Q4 2025 to $137.19 million in Q1 2026, marking four consecutive quarters of growth. Segment data reveals the growth engine is clearly the Infrastructure business at $62.81 million — the largest segment — followed by Broadband at $43.63 million, Connectivity at $18.60 million, and Industrial and multi-market at $12.15 million; the AI infrastructure build-out is the primary catalyst, with news reports citing 136% growth in that segment. This accelerating revenue trend, if sustained, materially strengthens the investment case by demonstrating that the AI-driven demand is translating into real top-line results rather than mere narrative.
Profitability remains the critical weak point: Q1 2026 net income was -$45.14 million on $137.19 million of revenue, a net margin of -32.90%, and EBITDA was -$7.32 million, though the gross margin of 57.50% is healthy for a fabless semiconductor company and has been stable-to-improving (55.50% in Q1 2025, 56.00% in Q2 2025, 56.58% in Q3 2025, 57.58% in Q4 2025, 57.50% in Q1 2026). The net loss narrowed dramatically from -$49.71 million in Q1 2025 to -$45.14 million in Q1 2026, but the Q1 2026 loss was inflated by a $26.49 million income tax expense and $53.16 million in R&D spending, which management is clearly prioritizing to capture the AI opportunity. Operating income remains negative at -$16.74 million (operating margin of -12.20%), and the company's -29.23% net margin and -27.13% operating margin are well below the profitability typical of mature semiconductor peers, though the trajectory from -51.82% net margin in Q1 2025 to -32.90% in Q1 2026 shows meaningful improvement.
The balance sheet is reasonably healthy but cash generation is inconsistent: debt-to-equity stands at 0.348, the current ratio is 1.338, and cash at the end of Q1 2026 was $89.93 million, down from $101.41 million at year-end 2025. Free cash flow turned negative in Q1 2026 at -$10.26 million (versus +$6.70 million in Q4 2025 and +$4.40 million in Q3 2025), with operating cash flow of -$8.87 million, driven by a $21.23 million working capital drain and $20.03 million in stock-based compensation. The TTM free cash flow of $10.15 million is positive but thin relative to the $1.51 billion market cap, and ROE of -30.25% and ROA of -4.89% reflect the ongoing losses; the company is not yet self-funding its growth and relies on its cash reserves and modest financing, which is manageable given the low debt load but leaves little margin for error if the AI demand cycle stalls.
Quarterly Revenue
$168847000.0B
2026-06
Revenue YoY Growth
+55.2%
YoY Comparison
Gross Margin
57.8%
Latest Quarter
Free Cash Flow
$3308000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MXL Overvalued?
Because MaxLinear's trailing net income is negative (EPS of -$0.09, net margin of -29.23%), the PE ratio is not meaningful and I have selected the PS ratio as the primary valuation metric, supplemented by the forward PE which becomes relevant given positive estimated EPS. The trailing PS ratio is 3.23x, while the forward PE is 35.91x based on estimated EPS of $3.53 — the existence of a positive forward PE alongside a negative trailing PE implies the market expects a dramatic swing to profitability, with the gap between the -11.03x trailing PE and 35.91x forward PE reflecting expectations of a full earnings inflection. The EV/Sales of 13.75x and EV/EBITDA of -27.28x further illustrate that the market is valuing this on future, not current, fundamentals.
Relative to the semiconductor industry, the PS ratio of 3.23x appears modest on the surface, but the EV/Sales of 13.75x tells a very different story — the wide gap between the two reflects the company's net cash position being relatively small versus its enterprise value, and the EV/Sales multiple is rich for a company with negative EBITDA. The PEG ratio of 0.239 is unusually low, suggesting that if the forward EPS estimates are achieved, the stock is cheap relative to its growth rate, but this metric is unreliable when the earnings base is transitioning from negative to positive. The PB ratio of 3.34x is moderate, and the forward PE of 35.91x represents a premium to the broader market but is arguably justified if the AI infrastructure growth trajectory (43% YoY revenue growth) is sustained; the key risk is that the market is capitalizing peak-cycle AI enthusiasm into a multiple that leaves no room for disappointment.
Historically, MaxLinear's PS ratio has ranged from a low of 8.95x (Q3 2022) to a high of 23.34x (Q4 2021), with the current trailing PS of 3.23x sitting well below that historical band — but this comparison is distorted because the historical PS ratios were calculated on a much smaller revenue base and the stock price has since appreciated dramatically. More instructive is the historical PE ratio, which swung from +73.35x in Q1 2023 to deeply negative readings through 2024-2025; the current forward PE of 35.91x is below the 2022-2023 positive PE readings of 20-73x, suggesting that on a forward basis the stock is not at a historical extreme. However, the PB ratio of 3.34x is near the middle of its historical range (2.19x to 11.83x), and the price-to-free-cash-flow ratio of 76.93x is elevated, indicating the market is paying a premium for cash flows that have yet to materialize at scale — a classic setup where the stock is priced for perfection on the AI narrative.
PE
-11.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 21x~103x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-27.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant, primarily stemming from the company's unprofitability and cash burn. In Q1 2026, MaxLinear reported a net loss of $45.14 million on $137.19 million in revenue, with a net margin of -32.9% and operating margin of -12.2%. Free cash flow turned negative at -$10.26 million, driven by a $21.23 million working capital drain and $20.03 million in stock-based compensation, leaving only $89.93 million in cash. Additionally, revenue is increasingly concentrated in the Infrastructure segment (45.8% of total), making the company vulnerable to a slowdown in AI-related demand. The debt-to-equity ratio of 0.348 is manageable, but the current ratio of 1.34 provides limited cushion if losses persist.
Market and competitive risks are amplified by the stock's extreme volatility and premium valuation. With a beta of 3.945, MXL is nearly four times as volatile as the broader market, meaning a 1% drop in the S&P 500 could theoretically lead to a ~4% decline in MXL. The EV/Sales multiple of 13.75x and price-to-free-cash-flow of 76.93x are rich for a company with negative EBITDA, leaving little room for disappointment. Competitive pressures from larger semiconductor firms like Broadcom and Qualcomm could intensify, especially in the AI infrastructure space where MaxLinear is a relatively small player with a market cap of $1.51 billion. Recent news highlights the AI narrative, but any negative developments, such as a major customer loss or a delay in AI projects, could trigger a sharp sell-off.
The worst-case scenario involves a combination of AI demand deceleration, continued cash burn, and a broader market rotation away from high-beta tech stocks. If the company fails to achieve profitability and revenue growth stalls, the stock could retest its 52-week low of $12.77, representing a potential decline of 86.4% from the current price of $93.84. Even a less severe scenario, such as a drop to the analyst low target of $40, would imply a 57.4% loss. Given the max drawdown of -55.28% observed in the past year, investors should be prepared for significant downside risk, with a realistic bear-case loss of 50-60% from current levels.
FAQ
The key risks include financial, competitive, macro, and company-specific factors. Financially, the company is unprofitable with negative free cash flow of -$10.26 million and a net margin of -32.9%. Competitively, larger players like Broadcom could pressure margins in the AI infrastructure space. Macro risks include high beta (3.945) making the stock vulnerable to market downturns. Company-specific risks include revenue concentration in the Infrastructure segment (45.8% of revenue) and the potential for a slowdown in AI capex. The most severe risk is a cash crunch leading to dilution, which could cause a 50-60% decline.
The 12-month forecast is based on three scenarios: bull (25% probability, target $125-140), base (50%, target $85-105), and bear (25%, target $40-60). The base case assumes revenue growth moderates to 25-30% YoY and the stock trades around the analyst average of $94.55. The bull case requires sustained AI momentum and profitability, while the bear case assumes a slowdown in AI spending and continued losses. The most likely scenario is the base case, with the key assumption that revenue growth remains above 25% and gross margins hold above 57%.
MXL appears fairly valued to slightly overvalued based on traditional metrics. The forward PE of 35.91x is a premium to the broader market, but the PEG ratio of 0.239 suggests undervaluation relative to growth if earnings materialize. However, the EV/Sales of 13.75x and price-to-free-cash-flow of 76.93x are elevated for a company with negative EBITDA. The PS ratio of 3.23x is below historical levels, but this is distorted by the revenue base. Overall, the market is pricing in significant future growth, leaving little room for disappointment.
MXL is a high-risk, high-reward stock that may be suitable for aggressive investors. The analyst consensus is 'buy' with an average target of $94.55, implying minimal upside from the current price of $93.84. The company's AI infrastructure segment grew 136%, driving 43% YoY revenue growth, but it remains unprofitable with a net margin of -32.9%. The stock's beta of 3.945 and max drawdown of -55.28% indicate extreme volatility. For those with a high risk tolerance and a long-term view, it could be a speculative buy on dips, but it is not a good buy for conservative investors.
MXL is more suitable for long-term investment by aggressive investors, given its high volatility and early-stage AI growth story. The stock's beta of 3.945 and max drawdown of -55.28% make it risky for short-term trading, as timing the market is difficult. The company does not pay dividends, so returns depend entirely on capital appreciation. A minimum holding period of 3-5 years is recommended to allow the AI infrastructure segment to mature and the company to achieve profitability. Short-term traders may find opportunities in the high volatility, but the risk of sharp losses is significant.